ABVC BioPharma ABVC
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 3.04 | 12 | -13.08 | -1 | -6.67 | 21 |
| 2025Q2 | 2.23 | 7 | -36.35 | -2 | -14.51 | 16 |
| 2025Q1 | 1.06 | 5 | -25.40 | -1 | -7.51 | 15 |
| 2024Q4 | 0.59 | 1 | -15.28 | -1 | -6.65 | 8 |
| 2024Q3 | 0.68 | 8 | -4.74 | 0 | -2.72 | 14 |
| 2024Q2 | 0.77 | 8 | -26.25 | -2 | -14.51 | 15 |
| 2024Q1 | 1.31 | 8 | -48.62 | -4 | -27.17 | 14 |
| 2023Q4 | 1.16 | 8 | -35.58 | -3 | -20.02 | 14 |
| 2023Q3 | 1.04 | 9 | -3 | -25.61 | 17 | |
| 2023Q2 | 5.20 | 0 | -2 | -22.58 | 9 | |
| 2023Q1 | 6.40 | 2 | -76.49 | -2 | -17.72 | 11 |
| 2022Q4 | 6.25 | 3 | -107.87 | -5 | -47.84 | 10 |
| 2022Q3 | 8.80 | 6 | -48.58 | -4 | -30.54 | 10 |
| 2022Q2 | 10.60 | 9 | -22.18 | -2 | -14.38 | 14 |
| 2022Q1 | 27.30 | 7 | -73.57 | -6 | -46.54 | 12 |
| 2021Q4 | 33.90 | 9 | -90.84 | -8 | -60.89 | 14 |
| 2021Q3 | 23.10 | 9 | -36.00 | -2 | -16.96 | 12 |
| 2021Q2 | 1 | -98.31 | -2 | -20.26 | 9 | |
| 2021Q1 | 3 | -37.57 | -1 | -10.20 | 11 | |
| 2020Q4 | 3 | -5 | -53.46 | 12 |